🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

8 recruiting trials

for Agitation Associated With Alzheimer's Disease Dementia

A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5) NCT06947941Phase 322 sites📍 Gilbert📍 Chino📍 Naples Bristol-Myers Squibb · Tests: KarXT, KarX-EC, KarXT + KarX-EC Arm Matching Placebo A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) NCT06937229Phase 3252 sites📍 Chandler📍 Scottsdale📍 Anaheim Bristol-Myers Squibb · Tests: KarXT, KarX-EC A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease NCT07011745Phase 3143 sites📍 Chandler📍 Chandler📍 Chandler Bristol-Myers Squibb · Tests: Xanomeline/Trospium Chloride Capsule, Xanomeline Enteric Capsule, Placebo A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1) NCT07011732Phase 3162 sites📍 Scottsdale📍 Anaheim📍 Fresno Bristol-Myers Squibb · Tests: Xanomeline/Trospium Chloride Capsule, Xanomeline Enteric Capsule, Placebo Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia NCT07284472Phase 2, Phase 349 sites📍 Murrieta📍 Indianapolis📍 Flowood Exciva GmbH · Tests: EXV-802, Placebo, EXV-801 A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia NCT06651567Phase 270 sites📍 Anaheim📍 Costa Mesa📍 Garden Grove Intra-Cellular Therapies, Inc. · Tests: ITI-1284, Placebo Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type NCT06052254Phase 210 sites📍 Chino📍 Daytona Beach📍 Delray Beach Teikoku Pharma USA, Inc. · Tests: 12 cm2 - 2 Active DMTS Patches, 6 cm2 - 1 Active and 1 Placebo DMTS Patches, Placebo - 2 Placebo DMTS Patches A Study of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia NCT06803823Phase 239 sites📍 Aichi📍 Akita📍 Akita Ono Pharmaceutical Co., Ltd. · Tests: ONO-2020, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy